Business Wire

Arm and Vodafone Commit to Work Together to Simplify Internet of Things (IoT) Deployment

Share

Arm and Vodafone today announced a strategic agreement that will significantly reduce complexity and costs faced by organisations when implementing Internet of Things (IoT) solutions. Expanding on the companies’ previous collaboration around integrated SIM (iSIM) technology, this partnership brings together Vodafone IoT global platform and connectivity, and Arm’s IoT software and services to provide enterprises with programmable, connected system on chip designs that eliminate the need for traditional SIM cards. This allows customers to securely deploy, remotely provision and manage massive numbers of IoT devices across global markets at a significantly lower cost and complexity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190225005318/en/

“Fragmentation, security and cost are three limiting factors in IoT, and we believe a strong partner ecosystem is critical in solving these challenges,” said Dipesh Patel, president, IoT Services Group, Arm. “This partnership will enable global enterprises to significantly reduce the cost and complexity of securely connecting their IoT devices at scale so that they can quickly drive real value and actionable insights from their IoT data through our Pelion IoT platform.”

“Vodafone has been focused on building its global IoT platform & connectivity, to enable the fast deployment of IoT services,” said Stefano Gastaut, IoT Director, Vodafone. “Working together with Arm, we will combine the strengths of both companies to benefit our customers and break down the barriers, such as cost and complexity, which are hindering the adoption of IoT for many.”

This strategic partnership between Arm and Vodafone enables remote provisioning for devices using Narrow Band-IoT (NB-IoT) and Long Term Evolution for Machines (LTE-M) technologies and provides secure, open, standards-based deployment to any application and service provider across the globe. Arm® Kigen™ iSIM provides anyone deploying IoT devices globally with the means to develop and deploy a single IoT product that can be shipped and connected anywhere in the world. Vodafone’s global IoT network enables organizations to connect IoT devices across the broadest global footprint through the Vodafone IoT platform or the Pelion™ IoT platform.

Arm and Vodafone’s leadership in NB-IoT and LTE-M technologies will unleash the potential of IoT by massively broadening the range of objects that can be connected and unlocking business and societal value. For example, using data from sensors on connected devices will help address challenges in feeding the earth’s growing population by improving yields of agriculture and livestock and reducing chemical and water use. This will also help utilities to more efficiently manage scarce resources such as water, gas and electricity and reduce carbon emissions.

This represents a major step towards enabling a wide ecosystem of device makers that will help businesses to tap into the potential of a trillion connected devices by 2035 and access the vast amount data they provide to drive better business outcomes. Joint solutions from Arm and Vodafone will be available in the first quarter of calendar year 2020.

About Vodafone
Vodafone Group is one of the world’s largest telecommunications companies and provides a range of services including voice, messaging, data and fixed communications. Vodafone Group has mobile operations in 25 countries, partners with mobile networks in 44 more, and fixed broadband operations in 19 markets. As of 31 December 2018, Vodafone Group had approximately 700 million mobile customers and 21 million fixed broadband customers, including all of the customers in Vodafone’s joint ventures and associates. For more information, please visit: www.vodafone.com.

About Arm
Arm technology is at the heart of a computing and connectivity revolution that is transforming the way people live and businesses operate. Our advanced, energy-efficient processor designs have enabled intelligent computing in more than 130 billion chips. More than 70% of the world’s population are using Arm technology, which is securely powering products from the sensor to the smartphone to the supercomputer. This technology combined with our IoT software and end-to-end connectivity, device and data management platform enables customers to derive real business value from their connected devices and data. Together with our 1,000+ technology partners we are at the forefront of designing, securing and managing all areas of compute from the chip to the cloud.

All information is provided "as is" and without warranty or representation. This document may be shared freely, attributed and unmodified. Arm is a registered trademark of Arm Limited (or its subsidiaries). All brands or product names are the property of their respective holders. © 1995-2018 Arm Group.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Enquiries:
Danielle Restivo
Head of Communications, Vodafone Business
danielle.restivo@vodafone.com

Evan Tamura
Senior PR and AR Manager, Arm
Evan.tamura@arm.com
+1 (714) 349-2301

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 Data for Incyte’s Retifanlimab (Zynyz ® ) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet13.6.2025 01:45:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced that primary results from the Phase 3 POD1UM-303/InterAACT 2 trial of retifanlimab (Zynyz®), a humanized monoclonal antibody targeting programmed death receptor-1 (PD-1), in combination with carboplatin and paclitaxel (platinum-based chemotherapy) in adult patients with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal cancer (SCAC) who have not been previously treated with systemic chemotherapy, were published in The Lancet.1 “The publication of the POD1UM-303/InterAACT 2 trial in The Lancet is a testament to the strength of the data generated for retifanlimab in patients with inoperable locally recurrent or metastatic SCAC, a disease which until recently had seen limited innovation for decades,” said Steven Stein, M.D., Chief Medical Officer, Incyte. “SCAC can be a devastating disease, and patients often have a poor prognosis. These data supported the U.S. Food and Drug Administration (FDA) approval of Zynyz® (retifanl

Güntner Drives Group-Wide Innovation in 2024 Sustainability Report12.6.2025 22:30:00 EEST | Press release

Güntner, a global leader in refrigeration and heat exchange technology, today announced its featured role in the newly released 2024 A-HEAT Sustainability Report. The report outlines significant progress toward ambitious environmental goals—fueled by Güntner’s commitment to measurable, innovation-led sustainability. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612897493/en/ Güntner advances global sustainability goals with progress in natural refrigerants, water savings, and circular economy efforts. Working toward its 2030 sustainability targets, Güntner delivered significant achievements across key areas including natural refrigeration integration, water and energy efficiency and the development of circular economy solutions. These efforts reflect Güntner’s ongoing mission to make sustainability not just a goal, but a core driver of innovation. Key milestones include a near-complete transition to natural refrigerants

Windsurf Launches First GPU Cluster in Germany, Expanding Secure Enterprise AI in Europe12.6.2025 21:45:00 EEST | Press release

Windsurf, a leader in AI-powered software development, today announced its first GPU cluster in Germany, as product demand surges and the company expands performance capacity across the EU. With over 100 local enterprise customers already using Windsurf products, the new cluster marks the company’s first major international step in building scalable infrastructure for the European market. Located in Frankfurt, home to some of the world’s strictest data security laws, the cluster was a natural choice for Windsurf’s first deployment. This cluster was specifically designed to meet the unique security and performance requirements of European enterprises, providing a framework for high performance in even the most complex, secure environments. “With about 6 million developers across Europe, users deserve infrastructure that meets them where they are,” said Varun Mohan, CEO of Windsurf. “The demand for secure AI-powered development is undeniable and by launching this GPU cluster, we aim to b

Xsolla Partners With Defold to Enable Seamless In-game Purchases for Web Developers12.6.2025 20:00:00 EEST | Press release

Xsolla, a leading global video game commerce company, announces a new strategic partnership with Defold, the cross-platform game engine trusted by professionals and indie developers worldwide. This collaboration introduces a seamless integration between Xsolla and Defold-built web games on CrazyGames, enabling developers to easily monetize their titles just in time for the CrazyGames x Defold Game Jam running June 13–15. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612569206/en/ (Graphic: Xsolla) To address the complexity of in-game monetization, Xsolla and Defold have developed a new SDK that allows Defold developers to implement in-game purchasing functionality without the complex manual API setup required. With Xsolla’s sponsorship and support, this integration removes friction from the monetization journey, allowing developers to focus on building engaging games, not commerce infrastructure. This SDK connects three

Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies12.6.2025 18:00:00 EEST | Press release

The Wellcome Sanger Institute, Parse Biosciences, and the Computational Health Center at Helmholtz Munich today announced a collaboration to build the foundation of a single cell atlas, focused on understanding and elucidating cancer plasticity in response to therapies. The collaboration will catalyze an ambitious future phase to develop a cancer plasticity atlas encompassing hundreds of millions of cells. Utilizing novel organoid perturbation and Artificial Intelligence (AI) platforms, the aim is to create a comprehensive dataset to fuel foundational drug discovery models and cancer research. Dr. Mathew Garnett, Group Leader at the Sanger Institute, and Prof. Fabian Theis, Director of the Computational Health Center at Helmholtz Munich and Associate Faculty at the Sanger Institute, will be the principal investigators in the collaboration. Garnett’s research team has generated novel 3D organoid cultures that serve as highly scalable and functional cancer models with the ability to capt

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye